Suppr超能文献

医疗保健有效性数据与信息集(HEDIS)物质使用障碍指标的范围综述。

A scoping review of healthcare effectiveness data and information set (HEDIS) substance use disorder measures.

作者信息

Goal Oliver Ethan, Amanda Isca, Adams Cameron, Grando Maria Adela

机构信息

College of Health Solutions, Arizona State University, Phoenix, Arizona, USA.

Arizona Health Care Cost Containment System, Phoenix, Arizona, USA.

出版信息

Ann Med. 2025 Dec;57(1):2447413. doi: 10.1080/07853890.2024.2447413. Epub 2025 Jan 2.

Abstract

INTRODUCTION

: There is a need to assess the delivery of interventions to improve substance use disorder (SUD) treatment, as measured by the Healthcare Effectiveness Data and Information Set (HEDIS®) metrics. The goal was to characterize published articles reporting HEDIS® SUD measures and recommend future work on applying and investigating SUD HEDIS® metrics and their effect on SUD treatments.

MATERIALS AND METHODS

The PRISMA-ScR scoping review protocol was used to find published work and investigate the most common reported baseline characteristics, HEDIS® metric outcomes, and knowledge gaps. Peer-reviewed papers available through PubMed, Academic Search Premier, Elsevier/ScienceDirect, and Medline were searched up to August 14, 2022.

RESULTS

: Twenty-eight articles were included after removing 92 duplications. Twenty-five articles were retrospective cohort studies, two were RCTs, and there was a mixed-method study. SUD metrics were studied in diverse settings, including ED, primary care, mental health care, and SUD specialty care. Twenty-seven papers utilized the Initiation and Engagement of Substance Use Disorder Treatment (IET) measure, and 13 had similar data sources, study populations, and authors. Eight papers presented IET results by substance used, primarily alcohol, cannabis, and opioids.

CONCLUSIONS

: More research is needed on the HEDIS® SUD metrics and their usefulness in informing SUD prevention and treatment, policy, and public health outcomes.

摘要

引言

需要评估干预措施的实施情况,以改善物质使用障碍(SUD)治疗,这通过医疗保健有效性数据和信息集(HEDIS®)指标来衡量。目标是对报告HEDIS® SUD指标的已发表文章进行特征描述,并就应用和研究SUD HEDIS®指标及其对SUD治疗的影响推荐未来的工作。

材料与方法

采用PRISMA-ScR范围综述方案来查找已发表的研究,并调查最常报告的基线特征、HEDIS®指标结果和知识空白。检索了截至2022年8月14日通过PubMed、学术搜索高级版、爱思唯尔/科学Direct和Medline可获取的同行评审论文。

结果

在去除92篇重复文章后,纳入了28篇文章。25篇文章为回顾性队列研究,2篇为随机对照试验,还有1篇混合方法研究。SUD指标在不同环境中进行了研究,包括急诊科、初级保健、精神卫生保健和SUD专科护理。27篇论文使用了物质使用障碍治疗的启动和参与(IET)指标,13篇论文有相似的数据源、研究人群和作者。8篇论文按使用的物质呈现了IET结果,主要是酒精、大麻和阿片类药物。

结论

需要对HEDIS® SUD指标及其在为SUD预防和治疗、政策及公共卫生结果提供信息方面的有用性进行更多研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92d5/11703095/d5b2558d622a/IANN_A_2447413_F0001_B.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验